Who owns the ONCOSIGNATURE trademark?

The ONCOSIGNATURE trademark is owned by Acrivon Therapeutics Inc..

What is the serial number for ONCOSIGNATURE?

The USPTO serial number for ONCOSIGNATURE is 79223972.

What is the registration number for ONCOSIGNATURE?

ONCOSIGNATURE is registered under USPTO registration number 5718472.

ONC

USPTO Trademark Record

REGISTERED

ONCOSIGNATURE

Q: What class is the ONCOSIGNATURE trademark registered in?

The ONCOSIGNATURE trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

SN 79223972·Reg 5718472·Filed Sep 22, 2017

Owner Acrivon Therapeutics Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

ONCOSIGNATURE (Serial No. 79223972), Registration No. 5718472, is a registered US trademark filed on Sep 22, 2017 by Acrivon Therapeutics Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

Section 8/9 declaration window: April 09, 2029

Mark Intelligence

ONCOSIGNATURE (Reg. #5718472) is a registered US trademark that has been protecting its owner, Acrivon Therapeutics Inc., since 2017. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 3 opposition proceedings during prosecution.

FILED

Sep 22, 2017

SERIAL

79223972

REG#

5718472

REGISTERED

Apr 09, 2019

Owner

Applicant

Acrivon Therapeutics Inc.

Entity

Corporation

Address

480 Arsenal Way, Suite 100, Watertown Massachusetts, 02472

Country

Attorney

NameSara M. Bauer

Law firm

Sara M. Bauer Womble Bond Dickinson (US) LLP

Docket

120194.0006

Address

470 Atlantic Ave; Suite 600, Independence Wharf, Boston, MA 02210, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateSep 22, 2017

Serial Number79223972

Registration No.5718472

Registration DateApr 09, 2019

Status DateFeb 10, 2026

Published for OppositionJan 22, 2019

Next RenewalApril 09, 2029

Mark TypeDesign with words

Attorney Docket120194.0006

Status DescriptionLive and registered, partial Section 71 accepted

Filing Signals

FILED

2017

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 3× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

Class 042Scientific, technology & SaaS services

US codes: 100, 101

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

50 events

LIMITATION FROM THE IB EXAMINED AND ENTERED

Jul 27, 2026

LIMITATION FROM THE IB EXAMINED AND ENTERED

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Jul 24, 2026

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

CORRECTION UNDER SECTION 7 - PROCESSED

Jul 24, 2026

CORRECTION UNDER SECTION 7 - PROCESSED

REGISTERED - PARTIAL SEC 71 ACCEPTED

Feb 10, 2026

REGISTERED - PARTIAL SEC 71 ACCEPTED

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

Feb 10, 2026

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Feb 09, 2026

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

TEAS SECTION 71 RECEIVED

Oct 07, 2025

TEAS SECTION 71 RECEIVED

LIMITATION OF GOODS RECEIVED FROM IB

Apr 18, 2025

LIMITATION OF GOODS RECEIVED FROM IB

TEAS VOLUNTARY AMENDMENT RECEIVED

Mar 12, 2025

TEAS VOLUNTARY AMENDMENT RECEIVED

NEW REPRESENTATIVE AT IB RECEIVED

Oct 04, 2024

NEW REPRESENTATIVE AT IB RECEIVED

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

Apr 09, 2024

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

CHANGE OF OWNER RECEIVED FROM IB

Feb 26, 2022

CHANGE OF OWNER RECEIVED FROM IB

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Jul 13, 2021

TEAS CHANGE OF OWNER ADDRESS RECEIVED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Jul 13, 2021

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Jul 13, 2021

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

Jul 13, 2021

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Jul 13, 2021

TEAS CHANGE OF CORRESPONDENCE RECEIVED

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Jul 13, 2021

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

FINAL DECISION TRANSACTION PROCESSED BY IB

Aug 16, 2019

FINAL DECISION TRANSACTION PROCESSED BY IB

FINAL DISPOSITION PROCESSED

Jul 31, 2019

FINAL DISPOSITION PROCESSED

FINAL DISPOSITION NOTICE SENT TO IB

Jul 31, 2019

FINAL DISPOSITION NOTICE SENT TO IB

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Jul 09, 2019

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

REGISTERED-PRINCIPAL REGISTER

Apr 09, 2019

REGISTERED-PRINCIPAL REGISTER

NOTIFICATION PROCESSED BY IB

Jan 25, 2019

NOTIFICATION PROCESSED BY IB

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Jan 25, 2019

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Jan 25, 2019

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

PUBLISHED FOR OPPOSITION

Jan 22, 2019

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jan 22, 2019

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

Jan 09, 2019

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Jan 09, 2019

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jan 02, 2019

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Dec 17, 2018

APPROVED FOR PUB - PRINCIPAL REGISTER

EXAMINERS AMENDMENT -WRITTEN

Dec 13, 2018

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Dec 13, 2018

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Dec 13, 2018

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Dec 13, 2018

EXAMINER'S AMENDMENT ENTERED

ASSIGNED TO EXAMINER

Aug 27, 2018

ASSIGNED TO EXAMINER

CORRESPONDENCE RECEIVED IN LAW OFFICE

Aug 03, 2018

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Aug 03, 2018

TEAS/EMAIL CORRESPONDENCE ENTERED

ASSIGNED TO LIE

Aug 02, 2018

ASSIGNED TO LIE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jul 18, 2018

TEAS RESPONSE TO OFFICE ACTION RECEIVED

REFUSAL PROCESSED BY IB

Feb 03, 2018

REFUSAL PROCESSED BY IB

REFUSAL PROCESSED BY MPU

Jan 18, 2018

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Jan 18, 2018

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

APPLICATION FILING RECEIPT MAILED

Jan 06, 2018

APPLICATION FILING RECEIPT MAILED

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Jan 06, 2018

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

NON-FINAL ACTION WRITTEN

Jan 05, 2018

NON-FINAL ACTION WRITTEN

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jan 02, 2018

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

ASSIGNED TO EXAMINER

Jan 02, 2018

ASSIGNED TO EXAMINER

SN ASSIGNED FOR SECT 66A APPL FROM IB

Dec 28, 2017

SN ASSIGNED FOR SECT 66A APPL FROM IB

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Recently filed and registered marks in the same international class.

ONC

ONCOSIGNATURE

98115652

Acrivon Therapeutics, Inc.

PENDING

ONCOSIGNATURE

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by Acrivon Therapeutics Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Sara M. Bauer

Resources

Company